Is biofilm production a prognostic marker in adults with candidaemia?

• DOI: 10.1016/j.cmi.2018.01.022
• Publication Date: 2018-03-24T19:55:03Z
• Authors: P. Muñoz; C. Agnelli; J. Guinea; A. Vena; A. Álvarez-Uría; L.J. Marcos-Zambrano; P. Escribano; M. Valerio; E. Bouza
• Keywords: Adult; 0301 basic medicine; Critical Care; Candidemia; Middle Aged; Prognosis; Biofilm formation; Candidaemia; Mortality; Prognosis; 3. Good health; 03 medical and health sciences; Risk Factors; Biofilms; Humans; Female; Biomass; Aged; Candida; Retrospective Studies

The role of biofilm production in the outcome of candidaemia remains under discussion. Current evidence relies on variable biofilm detection methods while evaluating distinct clinical end points. We aimed to determine the impact of biofilm production measured by metabolic activity (MA) and biomass (BM) on the prognosis of adults with candidaemia.Retrospective cohort including 280 adults with candidaemia admitted from 2010 to 2016. BM was assessed using crystal violet binding stain and the XTT reduction assay was used to detect MA. Strains were classified as high and moderate-low biofilm producers according to published cut-offs. The primary outcome was overall mortality within 7 and 30 days. The secondary outcome was unfavourable prognosis defined as metastatic infection, admission to an intensive care unit due to the severity of candidaemia, or death within 30 days.High BM and high MA were detected in 90 (32.1%) and 114 (40.7%) of the 280 isolates, respectively. Comparison of high and moderate-low biofilm forming isolates revealed no correlation between biofilm production and 7-day mortality (BM high 15/90 (16.7%) versus moderate-low 24/190 (12.6%); MA high 12/114 (10.5%) versus moderate-low 27/166 (16.3%)), 30-day mortality (BM high 34/90 (37.8%) versus moderate-low 61/190 (32.1%); MA high 33/114 (28.9%) versus moderate-low 62/166 (37.3%)), or unfavourable prognosis (BM high 45/90 (50.0%) versus moderate-low 73/190 (38.4%); MA high 41/114 (36.0%) versus moderate-low 77/166 (46.4%)).Biofilm production was not a predictor of mortality or of unfavourable prognosis in adults with candidaemia.